These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1718838)

  • 1. Silver staining of nucleolar organizer regions in prostatic lesions.
    Ghazizadeh M; Sasaki Y; Oguro T; Aihara K
    Histopathology; 1991 Oct; 19(4):369-72. PubMed ID: 1718838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in benign and malignant prostatic disease.
    Lloyd SN; Johnson CP; Brown IL; Kirk D
    Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
    Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
    Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
    Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
    Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions.
    Pavlakis K; Alivizatos G; Mitropoulos D; Constantinides C; Skopelitou A; Kittas C; Dimopoulos C
    Urol Int; 1992; 49(3):137-40. PubMed ID: 1281586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
    Cheville JC; Clamon GH; Robinson RA
    Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
    Deschênes J; Weidner N
    Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver staining nucleolar organizer region in prostate cytology.
    Bittinger A; von Keitz A; Rüschoff J; Melekos MD
    Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of argyrophil staining for nucleolar organizer regions (AgNORs) to pathologic diagnosis of prostatic adenocarcinoma].
    Cao X
    Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):232-3. PubMed ID: 9387689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions and PCNA expression in prostatic cancers.
    Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
    Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
    Mamaeva S; Lundgren R; Elfving P; Limon J; Mandahl N; Mamaev N; Henrikson H; Heim S; Mitelman F
    Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nucleolus organizer regions in prostatic intraepithelial neoplasm].
    Sentinelli S; Rondanelli E
    Pathologica; 1990; 82(1080):405-12. PubMed ID: 2284142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
    Hansen AB; Ostergård B
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereological estimation of nucleolar organizer regions in prostatic tissue with an optical disector.
    Hansen AB; Andersen CB
    APMIS; 1992 Feb; 100(2):135-41. PubMed ID: 1554487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AGNOR analyses of prostate carcinomas of high and malignancy].
    Helpap B; Riede C
    Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR).
    Konishi N; Nakaoka S; Tsuzuki T; Kitahori Y; Nishii K; Kitamura M; Ohshima M; Hiasa Y
    Pathol Int; 1994 Apr; 44(4):297-302. PubMed ID: 7519105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.